A study to assess the safety and tolerability of single doses of AZD4076 in healthy male subjects

Trial Identifier: D5590C00001
Sponsor: AstraZeneca
Start Date: November 2015
Primary Completion Date: November 2017
Study Completion Date: October 2025
Condition: Liver, Pancreas & Gallbladder - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Version

Trial Locations

Country Location
US, MD Brooklyn, MD, US, 21225